KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 171 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 2.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $102,291 | -83.7% | 57,146 | -6.0% | 0.00% | -66.7% |
| Q2 2021 | $627,000 | -93.9% | 60,786 | -93.8% | 0.00% | -94.6% |
| Q1 2021 | $10,314,000 | -32.0% | 980,464 | 0.0% | 0.06% | -52.1% |
| Q4 2020 | $15,178,000 | +594.3% | 980,464 | +554.7% | 0.12% | +350.0% |
| Q3 2020 | $2,186,000 | +1038.5% | 149,752 | +1397.5% | 0.03% | +1200.0% |
| Q1 2020 | $192,000 | -77.3% | 10,000 | -45.1% | 0.00% | -88.9% |
| Q2 2014 | $847,000 | – | 18,200 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,200,396 | $30,084,000 | 1.72% |
| TFS CAPITAL LLC | 105,040 | $987,000 | 0.26% |
| Tekla Capital Management LLC | 500,324 | $4,703,000 | 0.20% |
| Piermont Capital Management Inc. | 51,080 | $480,000 | 0.11% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 55,793 | $524,000 | 0.09% |
| Candriam S.C.A. | 390,000 | $3,666,000 | 0.08% |
| Virtus ETF Advisers LLC | 27,446 | $258,000 | 0.08% |
| SECOR Capital Advisors, LP | 66,484 | $625,000 | 0.08% |
| Trexquant Investment LP | 29,007 | $273,000 | 0.04% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 32,196 | $303,000 | 0.04% |